NEJM This Week

This episode highlights advances in treating prostate cancer, multiple myeloma, acute pain, and IgA nephropathy, alongside a review of platelet factor 4 disorders and a case of mucosal leishmaniasis.

This episode covers major advances in pancreatic and bladder cancer treatments, including Diraxon RASIB and Enfortumab-vidotin-pembrolizumab.